Rally today in Erie for Kanzius project Erie Times-News Fri, 30 Apr 2010 05:53 AM PDT The Kanzius Cancer Research Foundation will host a pep rally today at 5 p.m. at the Perry Square gazebo. Today is the final day to vote for the project in the Pepsi Refresh funding contest. | DNR concerned about burn barrels Milwaukee Journal Sentinel Fri, 30 Apr 2010 05:52 AM PDT Madison - State environmental officials say that backyard burn barrel could cause cancer. | Prostate cancer vaccine approved BBC News Fri, 30 Apr 2010 05:51 AM PDT A "vaccine" which uses the body's immune system to fight prostate cancer is approved for use by US drug regulators. | Finding cancer 'cold spots' can help minimize radiotherapy side-effects PhysOrg Fri, 30 Apr 2010 05:50 AM PDT Fine-tuning radiotherapy to take into account which parts of a patient's tumor are growing fastest could improve control of cancer while subjecting patients to lower doses of radiation, Dutch researchers reported today at the 2nd European Lung Cancer Conference. | Konica Minolto extends product devpt licensing pact with Guided Therapeutics PharmaBiz Fri, 30 Apr 2010 05:50 AM PDT Konica Minolta Opto, Inc (KMOT) of Tokyo has extended its licensing agreement to co-develop non-invasive cancer detection products with Guided Therapeutics, Inc (GT). Under terms of the agreement, KMOT will pay GT a US$ 750,000 fee to extend the agreement for one year. | Dr. Doug Schwartzentruber of Goshen, Ind. named one of TIME Magazines TIME 100 dBusinessNews.com Fri, 30 Apr 2010 05:48 AM PDT Indianapolis - GOSHEN, Ind. â" Today, TIME Magazine announced that Dr. Doug Schwarztentruber, Medical Director of Goshen Health Systemâs Goshen Center for Cancer Care, has been named to the 2010 TIME 100, the magazineâs annual list of the 100 most influential people in the world. | Breakthrough cancer therapy is a go - for $93K Daily Record Fri, 30 Apr 2010 05:47 AM PDT The Food and Drug Administration on Thursday approved the first vaccine to treat prostate cancer - or any cancer - the culmination of decades of research into harnessing the immune system to fight tumors. | FDA OKs drug to help fight prostate cancer Chicago Sun-Times Fri, 30 Apr 2010 05:46 AM PDT A cancer vaccine that stimulates the immune system to fight advanced prostate cancer was approved Thursday by the Food and Drug Administration , the first time a therapy of this kind has been approved to treat cancer. The vaccine, Provenge, isn't a cure for cancer. And it doesn't prevent men from getting prostate cancer. But Provenge does appear to modestly prolong survival in men whose cancer ... | | |
|
No comments:
Post a Comment